Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

Mikulska, Malgorzata; Averbuch, Diana; Tissot, Frederic; Cordonnier, Catherine; AKOVA, MURAT; Calandra, Thierry; Ceppi, Marcello; Bruzzi, Paolo; Viscoli, Claudio

doi:10.1016/j.jinf.2017.10.009

Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

Atıf İçin Kopyala

Mikulska M., Averbuch D., Tissot F., Cordonnier C., AKOVA M., Calandra T., ...Daha Fazla

JOURNAL OF INFECTION, cilt.76, sa.1, ss.20-37, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 76 Sayı: 1
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.jinf.2017.10.009
Dergi Adı: JOURNAL OF INFECTION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.20-37
Hacettepe Üniversitesi Adresli: Evet

Özet

Objectives: Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infections in Leukemia (ECIL) for patients with prolonged neutropenia. In consideration of a worldwide increase in antibiotic resistance, the issue of FQ prophylaxis during neutropenia was re-evaluated.